AIM WINNERS & LOSERS: Totally swings to half-year loss on NHS blow
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
Read more(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read more(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News:
Read more(Sharecast News) - Preclinical antibody developer Fusion Antibodies announced the immediate appointment of Stephen Smyth as its interim chief financial officer on Thursday.
Read moreFusion Antibodies PLC - Belfast-based contract research organisation providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Appoints Stephen Smyth as interim chief financial officer with immediate effect. Smyth was previously CFO at Sera Global LP, and has held senior finance positions at Cormark Securities Inc and PricewaterhouseCoopers LLP. He is currently a partner at FPM Accountants Ltd.
Read more(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies updated the market on its 'AI/ML-Ab', or AIM-Lab, service on Monday.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.
Read more(Alliance News) - Fusion Antibodies PLC on Monday said it signed an agreement with an unnamed artificial intelligence & machine learning company, which it said could cut costs per sequence test significantly.
Read more(Alliance News) - Fusion Antibodies PLC on Monday said it has completed its restructuring plans, in hopes of reducing annualised costs by about GBP2.2 million.
Read moreFriday 2 June | |
Cap-XX Ltd | GM re fundraising |
Conduity Capital PLC | GM re future direction of the company |
Kibo Energy PLC | EGM re renewal of director authorisations to issue shares |
Mirriad Advertising PLC | GM re new ordinary shares admitted to trading on AIM |
Purplebricks Group PLC | GM re proposed sale of business & assets to Strike Ltd |
Monday 5 June | |
EnQuest PLC | AGM |
Tuesday 6 June | |
Billington Holdings PLC | AGM |
Mast Energy Developments PLC | AGM |
NB Global Monthly Income Fund Ltd | AGM |
Tasty PLC | AGM |
WANdisco PLC | GM re new shares authorisation and fundraise |
Wednesday 7 June | |
City Pub Group PLC | AGM |
Gem Diamonds Ltd | AGM |
Gulf Marine Services PLC | AGM |
Hostmore PLC | AGM |
LXi REIT PLC | AGM |
Pennant International Group PLC | AGM |
Third Point Investors Ltd | AGM |
United Oil & Gas PLC | AGM |
Xpediator PLC | GM re takeover by DLM Bidco |
Thursday 8 June | |
Ashtead Technology Holdings PLC | AGM |
Camellia PLC | AGM |
Checkit PLC | AGM |
Churchill China PLC | AGM |
CRH PLC | Court Meeting and EGM re proposal to transfer the company's primary listing to NYSE |
Downing Renewables & Infrastructure Trust PLC | AGM |
Fair Oaks Income Ltd | AGM |
Fusion Antibodies PLC | GM re result of retail offer |
Genflow Biosciences PLC | AGM |
Glenveagh Properties PLC | AGM |
Kavango Resources PLC | AGM |
Kosmos Energy Ltd | AGM |
Melrose Industries PLC | AGM |
North American Income Trust PLC | AGM |
Oriole Resources PLC | AGM |
Panther Metals PLC | AGM |
REA Holdings PLC | AGM |
Renalytix PLC | GM re director's authorization to allot new shares and equity securities for cash |
Vaalco Energy Inc | AGM |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
Fusion Antibodies PLC - Belfast-based contract research organisation providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Raises GBP1.6 million through a placing and director subscription of 31.2 million shares at 5 pence per share, which is an 84% discount to the stock's close on Thursday of 32.06p. The placing is run by broker Allenby Capital Ltd. Fusion also launches a separate retail offer via the REX platform of up to 10.0 million shares at the same price, to raise up to an additional GBP500,000.
Read more(Alliance News) - Fusion Antibodies PLC on Tuesday said it has filed a patent application for a panel of antibodies that bind to an important target for cancer therapeutics.
Read more(Sharecast News) - Contract research organisation Fusion Antibodies issued a revenue warning on Monday, after a "challenging" first six months of trading as a number of valuable projects were suspended by clients due to delayed investment.
Read more(Alliance News) - Stock prices in London were largely lower at midday on Monday, with the FTSE 100 trading in the red, weighed down by poor performances by mining stocks.
Read more(Alliance News) - Fusion Antibodies PLC on Monday said it expects annual revenue to be significantly below expectations as a result of continued uncertainty in the timings of orders.
Read more